Omega-3 Fatty Acids (DHA/EPA) لـ Age-Related Cognitive Decline
A الأدلة تُظهر تجارب سريرية كبيرة متعددة باستمرار فوائد ملحوظة.A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.
الخلاصة
A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.
Key Study Findings
المجتمع المدروس: None
المجتمع المدروس: None
المجتمع المدروس: None
المجتمع المدروس: Male Sprague Dawley rats with MSG-induced neurotoxicity
المجتمع المدروس: Review of CoQ10 supplementation and cognition
المجتمع المدروس: Review of natural products for neuroprotection
Key Statistics
58
الدراسات
12000
المشاركون
Positive
التقييم
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
الجرعات الشائعة
- general:
- 1,000-2,000 mg combined DHA/EPA per day
- cognitivesupport:
- 1,000-1,700 mg/day (optimal dose-response curve)
الحد الأعلى: 3,000 mg/day combined DHA/EPA (FDA GRAS)
الجرعات المدروسة في الأبحاث
| الجرعة | المدة | التأثير | ن |
|---|---|---|---|
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| Vit D 1 mcg/kg + N-3 PUFA 300 mg/kg EPA+DHA | 4 weeks | Positive | 50 |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
أفضل وقت للتناول: With meals containing fat for better absorption
Safety & Side Effects
الآثار الجانبية المُبلّغ عنها
- ⚠ Fishy aftertaste or burping
- ⚠ Mild gastrointestinal discomfort
- ⚠ Potential increased bleeding time at very high doses
- ⚠ May lower blood pressure slightly
التفاعلات المعروفة
- ● Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
- ● Blood pressure medications (additive hypotensive effect)
- ● Orlistat (may reduce omega-3 absorption)
الحد الأقصى المسموح به: 3,000 mg/day combined DHA/EPA (FDA GRAS)
استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.
Frequently Asked Questions
Does Omega-3 Fatty Acids (DHA/EPA) help with Age-Related Cognitive Decline?
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Age-Related Cognitive Decline?
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Age-Related Cognitive Decline?
Related Evidence
مكونات أخرى لـ Age-Related Cognitive Decline
Omega-3 Fatty Acids (DHA/EPA) لحالات أخرى
References
- [1] Vicente Javier Clemente-Suárez et al.. Nutrients. 2025. Impact of Vegan and Vegetarian Diets on Neurological Health: A Critical Review. doi:10.3390/nu17050884 PubMed
- [2] Rarchita Sharma et al.. Nutr Neurosci. 2025. Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection. doi:10.1080/1028415X.2025.2469170 PubMed
- [3] Mervin Chávez-Castillo et al.. Molecules. 2025. Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer's Disease. doi:10.3390/molecules30153057 PubMed
- [4] Paola Gualtieri et al.. Nutrients. 2025. Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease. doi:10.3390/nu17050922 PubMed
- [5] Mehmet Kanbay et al.. Eur J Clin Invest. 2025. Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions. doi:10.1111/eci.70045 PubMed
- [6] Punyatoya Panda et al.. J Proteome Res. 2025. Multiplatform Lipid Analysis of the Brain of Aging Mice by Mass Spectrometry. doi:10.1021/acs.jproteome.4c00688 PubMed
- [7] Ali Rezaei et al.. Ann Med Surg (Lond). 2025. Can supplementation with antioxidants improve cognitive functions in patients with multiple sclerosis? A literature review. doi:10.1097/MS9.0000000000003124 PubMed
- [8] Larissa Parreira Araújo et al.. Int J Mol Sci. 2025. Sarcopenia in the Aging Process: Pathophysiological Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches. doi:10.3390/ijms262412147 PubMed
- [9] Guilherme Christimann et al.. J Alzheimers Dis. 2025. Bioactive compounds and dietary patterns in Alzheimer's disease. doi:10.1177/13872877251319048 PubMed
- [10] Rasha Z Alshahawy et al.. Sci Rep. 2025. Vitamin D and omega-3 fatty acids attenuate MSG-induced neurodegeneration by modulating tau pathology, neuroinflammation, and VDR expression in rats. doi:10.1038/s41598-025-06109-3 PubMed
- [11] Madeleine C Nankivell et al.. Nutrients. 2025. Coenzyme Q10 and Cognition: A Review. doi:10.3390/nu17172896 PubMed
- [12] Ozra Tabatabaei-Malazy et al.. Handb Exp Pharmacol. 2025. The Use of Natural Products for Preventing Cognitive Decline/Providing Neuroprotection. doi:10.1007/164_2024_732 PubMed
- [13] Feng Gu et al.. Asia Pac J Clin Nutr. 2025. Effects of plant-derived dietary antioxidants on Alzheimer's disease: Focus on ferroptosis. doi:10.6133/apjcn.202512_34(6).0007 PubMed
- [14] Xiaopeng Li et al.. Neurochem Res. 2025. Targeting Liquid-Liquid Phase Separation and Autophagy in Alzheimer's Disease: Insights into Molecular Mechanisms and Therapeutic Potential. doi:10.1007/s11064-025-04623-4 PubMed
- [15] Bruno S Goncalves et al.. Front Nutr. 2025. Nutritional strategies against dementia in rural populations. doi:10.3389/fnut.2025.1677197 PubMed
- [16] Prabhash Nath Tripathi et al.. Degener Neurol Neuromuscul Dis. 2024. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. doi:10.2147/DNND.S452009 PubMed
- [17] JinJin Pei et al.. Ageing Res Rev. 2024. Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review. doi:10.1016/j.arr.2024.102393 PubMed
- [18] Francine K Welty et al.. Arterioscler Thromb Vasc Biol. 2024. Fish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive Function. doi:10.1161/ATVBAHA.122.318125 PubMed
- [19] Xavier Morató et al.. J Alzheimers Dis. 2024. Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's Disease. doi:10.3233/JAD-231372 PubMed
- [20] Ernesto Calderon Martinez et al.. Neuropsychopharmacol Rep. 2024. The effects of omega-3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systematic review and meta-analysis. doi:10.1002/npr2.12455 PubMed
- [21] Debasis Sen et al.. Curr Alzheimer Res. 2024. Comprehensive Insights into Pathophysiology of Alzheimer's Disease: Herbal Approaches for Mitigating Neurodegeneration. doi:10.2174/0115672050309057240404075003 PubMed
- [22] Murtaza Haidary et al.. Int J Dev Neurosci. 2024. Omega-3 fatty acids supplementation prevents learning and memory impairment induced by chronic ethanol consumption in adolescent male rats through restoration … doi:10.1002/jdn.10336 PubMed
- [23] Gaurav Vijayrao Deshmukh et al.. Cureus. 2024. The Role of Omega-3 Fatty Acid Supplementation in Slowing Cognitive Decline Among Elderly Patients With Alzheimer's Disease: A Systematic Review … doi:10.7759/cureus.73390 PubMed
- [24] Da-Sol Kim et al.. Int J Mol Sci. 2024. Zeaxanthin and Lutein Ameliorate Alzheimer's Disease-like Pathology: Modulation of Insulin Resistance, Neuroinflammation, and Acetylcholinesterase Activity in an Amyloid-β Rat Model. doi:10.3390/ijms25189828 PubMed
- [25] Bao-Zhen Wei et al.. Am J Clin Nutr. 2023. The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, … doi:10.1016/j.ajcnut.2023.04.001 PubMed
- [26] Francine K Welty. Curr Opin Lipidol. 2023. Omega-3 fatty acids and cognitive function. doi:10.1097/MOL.0000000000000862 PubMed
- [27] Ping-Tao Tseng et al.. Brain Behav Immun. 2023. Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer's dementia: A network meta-analysis of randomized, placebo-controlled trials … doi:10.1016/j.bbi.2023.04.017 PubMed
- [28] Victoria Andrews et al.. Nutr Rev. 2023. Dietary pattern, food, and nutritional supplement effects on cognitive outcomes in mild cognitive impairment: a systematic review of previous reviews. doi:10.1093/nutrit/nuad013 PubMed
- [29] Li Zhou et al.. Nutr Hosp. 2023. Vitamin B12 supplementation improves cognitive function in middle aged and elderly patients with cognitive impairment. doi:10.20960/nh.04394 PubMed
- [30] Toshiaki Sueyasu et al.. Nutrients. 2023. Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin on Episodic Memory in Healthy Older Adults. doi:10.3390/nu15132825 PubMed
- [31] Tiarnan D L Keenan et al.. Alzheimers Dement. 2023. Dietary nutrient intake and cognitive function in the Age-Related Eye Disease Studies 1 and 2. doi:10.1002/alz.13033 PubMed
- [32] Rebecca Power et al.. Clin Nutr. 2022. Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial. doi:10.1016/j.clnu.2021.12.004 PubMed
- [33] Victoria Gil Martínez et al.. Nutrients. 2022. Vitamin Supplementation and Dementia: A Systematic Review. doi:10.3390/nu14051033 PubMed
- [34] Pan-Yen Lin et al.. Brain Behav Immun. 2022. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial. doi:10.1016/j.bbi.2021.10.014 PubMed
- [35] Amy H R Wood et al.. Eur J Nutr. 2022. Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer's disease. doi:10.1007/s00394-021-02655-4 PubMed
- [36] Ignasi Mora et al.. Int J Mol Sci. 2022. Structured Long-Chain Omega-3 Fatty Acids for Improvement of Cognitive Function during Aging. doi:10.3390/ijms23073472 PubMed
- [37] Alzbeta Katonova et al.. Int J Mol Sci. 2022. Effect of a Vegan Diet on Alzheimer's Disease. doi:10.3390/ijms232314924 PubMed
- [38] Laure Rouch et al.. Am J Clin Nutr. 2022. Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's disease neuroimaging initiative: cross-sectional and … doi:10.1093/ajcn/nqac236 PubMed
- [39] Caroline S Duchaine et al.. J Nutr. 2022. Serum ω-3 Fatty Acids and Cognitive Domains in Community-Dwelling Older Adults from the NuAge Study: Exploring the Associations with Other … doi:10.1093/jn/nxac110 PubMed
- [40] Julie Gregory et al.. Biomolecules. 2021. Neuroprotective Herbs for the Management of Alzheimer's Disease. doi:10.3390/biom11040543 PubMed
- [41] John E Lewis et al.. J Clin Transl Res. 2021. The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. PubMed
- [42] Cindy Crawford et al.. J Altern Complement Med. 2021. Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review. doi:10.1089/acm.2021.0135 PubMed
- [43] Barbara Troesch et al.. Nutrients. 2020. Expert Opinion on Benefits of Long-Chain Omega-3 Fatty Acids (DHA and EPA) in Aging and Clinical Nutrition. doi:10.3390/nu12092555 PubMed
- [44] Manuela Pennisi et al.. Nutrients. 2020. Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update. doi:10.3390/nu12051389 PubMed
- [45] Aline Thomas et al.. Alzheimers Dement. 2020. Blood polyunsaturated omega-3 fatty acids, brain atrophy, cognitive decline, and dementia risk. doi:10.1002/alz.12195 PubMed
- [46] Julia C Kuszewski et al.. J Nutr. 2020. Evaluation of Cognitive Performance following Fish-Oil and Curcumin Supplementation in Middle-Aged and Older Adults with Overweight or Obesity. doi:10.1093/jn/nxaa299 PubMed
- [47] Kirsten M Wright et al.. Drug Metab Dispos. 2020. Centella asiatica Water Extract Shows Low Potential for Cytochrome P450-Mediated Drug Interactions. doi:10.1124/dmd.120.090860 PubMed
- [48] Ying-Cai Zhao et al.. Lipids Health Dis. 2020. Recovery of brain DHA-containing phosphatidylserine and ethanolamine plasmalogen after dietary DHA-enriched phosphatidylcholine and phosphatidylserine in SAMP8 mice fed with high-fat … doi:10.1186/s12944-020-01253-3 PubMed
- [49] G C Román et al.. Rev Neurol (Paris). 2019. Mediterranean diet: The role of long-chain ω-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and … doi:10.1016/j.neurol.2019.08.005 PubMed
- [50] Andrea M McGrattan et al.. Curr Nutr Rep. 2019. Diet and Inflammation in Cognitive Ageing and Alzheimer's Disease. doi:10.1007/s13668-019-0271-4 PubMed
- [51] Amelia Martí Del Moral et al.. Nutr Hosp. 2019. Omega-3 fatty acids and cognitive decline: a systematic review. doi:10.20960/nh.02496 PubMed
- [52] Paul Fairbairn et al.. Prostaglandins Leukot Essent Fatty Acids. 2019. Combining a high DHA multi-nutrient supplement with aerobic exercise: Protocol for a randomised controlled study assessing mobility and cognitive function … doi:10.1016/j.plefa.2019.04.001 PubMed
- [53] Amy Locke et al.. Am Fam Physician. 2018. Diets for Health: Goals and Guidelines. PubMed
- [54] Arrigo F G Cicero et al.. Pharmacol Res. 2018. Botanicals and phytochemicals active on cognitive decline: The clinical evidence. doi:10.1016/j.phrs.2017.12.029 PubMed
- [55] Rosa María Martínez García et al.. Nutr Hosp. 2018. [Nutrition strategies that improve cognitive function]. doi:10.20960/nh.2281 PubMed
- [56] Durga Chapagain et al.. Front Psychol. 2018. Effect of Age and Dietary Intervention on Discrimination Learning in Pet Dogs. doi:10.3389/fpsyg.2018.02217 PubMed
- [57] Shibu M Poulose et al.. Adv Nutr. 2017. Nutritional Factors Affecting Adult Neurogenesis and Cognitive Function. doi:10.3945/an.117.016261 PubMed
- [58] Luta Luse Basambombo et al.. Ann Pharmacother. 2017. Use of Vitamin E and C Supplements for the Prevention of Cognitive Decline. doi:10.1177/1060028016673072 PubMed
- [59] Milan Fiala et al.. FASEB J. 2017. Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids. doi:10.1096/fj.201700065R PubMed
- [60] Tanya Gwendolyn Nock et al.. Biochim Biophys Acta Mol Cell Biol Lipids. 2017. Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and … doi:10.1016/j.bbalip.2017.07.004 PubMed
- [61] Jessay Gopuran Devassy et al.. Adv Nutr. 2016. Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease. doi:10.3945/an.116.012187 PubMed
- [62] Abderrahim Oulhaj et al.. J Alzheimers Dis. 2016. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. doi:10.3233/JAD-150777 PubMed
- [63] Katherine L Tucker. Ann N Y Acad Sci. 2016. Nutrient intake, nutritional status, and cognitive function with aging. doi:10.1111/nyas.13062 PubMed
- [64] Xiao-Wei Zhang et al.. Aging Clin Exp Res. 2016. Omega-3 fatty acids and risk of cognitive decline in the elderly: a meta-analysis of randomized controlled trials. doi:10.1007/s40520-015-0381-9 PubMed
- [65] Philippa A Jackson et al.. Nutrients. 2016. DHA Supplementation Alone or in Combination with Other Nutrients Does not Modulate Cerebral Hemodynamics or Cognitive Function in Healthy Older … doi:10.3390/nu8020086 PubMed
- [66] Richa Rathod et al.. J Biomed Sci. 2016. Novel insights into the effect of vitamin B₁₂ and omega-3 fatty acids on brain function. doi:10.1186/s12929-016-0241-8 PubMed
- [67] P Lehert et al.. Climacteric. 2015. Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis. doi:10.3109/13697137.2015.1078106 PubMed
- [68] Shengyuan Wang et al.. PLoS One. 2015. Protective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's Disease. doi:10.1371/journal.pone.0143135 PubMed
- [69] Debora Cutuli et al.. Front Aging Neurosci. 2014. n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice. doi:10.3389/fnagi.2014.00220 PubMed
- [70] Alessio Molfino et al.. Nutrients. 2014. The role for dietary omega-3 fatty acids supplementation in older adults. doi:10.3390/nu6104058 PubMed
- [71] Ananya Sadhu et al.. Clin Drug Investig. 2014. Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product. doi:10.1007/s40261-014-0235-9 PubMed
- [72] S Engelborghs et al.. Acta Clin Belg. 2014. Rationale and clinical data supporting nutritional intervention in Alzheimer's disease. doi:10.1179/0001551213Z.0000000006 PubMed
- [73] Abdul-Razak Abubakari et al.. Int J Gen Med. 2014. Omega-3 fatty acid supplementation and cognitive function: are smaller dosages more beneficial? doi:10.2147/IJGM.S67065 PubMed
- [74] Dan L Waitzberg et al.. Nutr Hosp. 2014. [Contribution of omega-3 fatty acids for memory and cognitive function]. doi:10.3305/nh.2014.30.3.7632 PubMed
- [75] Tommy Cederholm et al.. Adv Nutr. 2013. ω-3 fatty acids in the prevention of cognitive decline in humans. doi:10.3945/an.113.004556 PubMed
- [76] I Denis et al.. Ageing Res Rev. 2013. Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms. doi:10.1016/j.arr.2013.01.007 PubMed
- [77] Martin Loef et al.. J Nutr Gerontol Geriatr. 2013. The omega-6/omega-3 ratio and dementia or cognitive decline: a systematic review on human studies and biological evidence. doi:10.1080/21551197.2012.752335 PubMed
- [78] Eric M Ammann et al.. Neurology. 2013. ω-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCA. doi:10.1212/WNL.0b013e3182a9584c PubMed
- [79] Joann E Manson et al.. Contemp Clin Trials. 2012. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and … doi:10.1016/j.cct.2011.09.009 PubMed
- [80] Noemí Fabelo et al.. Mol Med. 2011. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease. doi:10.2119/molmed.2011.00119 PubMed
- [81] Cécilia Samieri et al.. Neurobiol Aging. 2011. ω-3 fatty acids and cognitive decline: modulation by ApoEε4 allele and depression. doi:10.1016/j.neurobiolaging.2010.03.020 PubMed
- [82] Gene L Bowman et al.. Alzheimer Dis Assoc Disord. 2011. Reliability and validity of food frequency questionnaire and nutrient biomarkers in elders with and without mild cognitive impairment. doi:10.1097/WAD.0b013e3181f333d6 PubMed
- [83] Michael J Serby et al.. Curr Treat Options Neurol. 2011. Treatment of memory loss with herbal remedies. doi:10.1007/s11940-011-0135-8 PubMed
- [84] Sally A Frautschy et al.. Mol Neurobiol. 2010. Why pleiotropic interventions are needed for Alzheimer's disease. doi:10.1007/s12035-010-8137-1 PubMed
- [85] Tina L Huang. J Alzheimers Dis. 2010. Omega-3 fatty acids, cognitive decline, and Alzheimer's disease: a critical review and evaluation of the literature. doi:10.3233/JAD-2010-090934 PubMed
- [86] A Chan et al.. J Nutr Health Aging. 2010. A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia. doi:10.1007/s12603-010-0054-5 PubMed
- [87] Tommy Cederholm et al.. Curr Opin Clin Nutr Metab Care. 2010. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? doi:10.1097/MCO.0b013e328335c40b PubMed
- [88] Jennifer G Robinson et al.. Womens Health (Lond). 2010. Omega-3 fatty acids and cognitive function in women. doi:10.2217/whe.09.75 PubMed
- [89] Louise A Brown et al.. Exp Aging Res. 2010. Supplementing cognitive aging: a selective review of the effects of ginkgo biloba and a number of everyday nutritional substances. doi:10.1080/03610730903417960 PubMed
- [90] Lei Feng. JAMA. 2010. Ginkgo biloba and cognitive decline. doi:10.1001/jama.2010.434 PubMed
- [91] Klaus P Ebmeier. Practitioner. 2010. Normal cognitive decline or dementia? PubMed
- [92] Majid Fotuhi et al.. Nat Clin Pract Neurol. 2009. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. doi:10.1038/ncpneuro1044 PubMed
- [93] Beth E Snitz et al.. JAMA. 2009. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. doi:10.1001/jama.2009.1913 PubMed
- [94] Jacqueline Birks et al.. Cochrane Database Syst Rev. 2009. Ginkgo biloba for cognitive impairment and dementia. doi:10.1002/14651858.CD003120.pub3 PubMed
- [95] Greg M Cole et al.. Prostaglandins Leukot Essent Fatty Acids. 2009. Omega-3 fatty acids and dementia. doi:10.1016/j.plefa.2009.05.015 PubMed
- [96] James Suchy et al.. Nutr Res. 2009. Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain … doi:10.1016/j.nutres.2008.11.004 PubMed
- [97] Elizabeth J Johnson et al.. Nutr Neurosci. 2008. Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. doi:10.1179/147683008X301450 PubMed
- [98] Wei Wang et al.. J Alzheimers Dis. 2008. Nutritional biomarkers in Alzheimer's disease: the association between carotenoids, n-3 fatty acids, and dementia severity. doi:10.3233/jad-2008-13103 PubMed
- [99] Marek Jarema. Neuro Endocrinol Lett. 2008. Herbal drug treatment. PubMed
- [100] Parris M Kidd. Altern Med Rev. 2008. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. PubMed
- [101] J Birks et al.. Cochrane Database Syst Rev. 2007. Ginkgo biloba for cognitive impairment and dementia. doi:10.1002/14651858.CD003120.pub2 PubMed
- [102] Parris M Kidd. Altern Med Rev. 2007. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. PubMed
- [103] Erika Freemantle et al.. Prostaglandins Leukot Essent Fatty Acids. 2006. Omega-3 fatty acids, energy substrates, and brain function during aging. doi:10.1016/j.plefa.2006.05.011 PubMed
- [104] J M Bourre. J Nutr Health Aging. 2005. Dietary omega-3 Fatty acids and psychiatry: mood, behaviour, stress, depression, dementia and aging. PubMed
- [105] Jean-Marie Bourre. Med Sci (Paris). 2005. [Omega-3 fatty acids in psychiatry]. doi:10.1051/medsci/2005212216 PubMed
- [106] M Malouf et al.. Cochrane Database Syst Rev. 2003. Folic acid with or without vitamin B12 for cognition and dementia. doi:10.1002/14651858.CD004514 PubMed
- [107] Danielle Laurin et al.. J Alzheimers Dis. 2003. Omega-3 fatty acids and risk of cognitive impairment and dementia. doi:10.3233/jad-2003-5407 PubMed
- [108] L A Horrocks et al.. Pharmacol Res. 1999. Health benefits of docosahexaenoic acid (DHA). doi:10.1006/phrs.1999.0495 PubMed
- [109] P M Kidd. Altern Med Rev. 1999. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. PubMed
إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.